Methylphenidate vs placebo
Change in global disease severity · Apathy in people with mild‐to‐moderate Alzheimer's disease
Methylphenidate showed no clear difference in change in global disease severity compared with placebo (moderate certainty).
1 finding from 1 review
- Pharmacological interventions for apathy in Alzheimer's disease 2018 · Cochrane Headline outcomes onlyRR 0.56 [0.15, 2.1]2 studies · 85 participantsModerate